| Exchange | Long/Short Term | Stage | Entry date | Exit date |
|---|---|---|---|---|
| BSE | GSM | Stage 0 | 15 Dec 2023 | 10 Mar 2025 |
| Exchange | Long/Short Term | Stage | Entry date | Exit date |
|---|---|---|---|---|
| BSE | GSM | Stage 0 | 15 Dec 2023 | 10 Mar 2025 |
No, HPC Biosciences Ltd. has not been shortlisted under Additional Surveillance Measure (ASM).
No, HPC Biosciences Ltd. has not been shortlisted under Graded Surveillance Measure (GSM).
HPC Biosciences Ltd. exited Graded Surveillance Measure (GSM) on 10 Mar, 2025.
Graded Surveillance Measure (GSM) is one of many surveillance measures implemented, by SEBI and Exchanges, on securities with price not commensurate with financial health and fundamentals like Earnings, Book value, Fixed assets, Net-worth, P/E multiple, Market Capitalisation etc.
The shortlisting of securities under Graded Surveillance Measure (GSM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.
The detailed criteria for shortlisting & review of securities under GSM Framework is given below:
Criteria I:
The following criteria shall be made applicable for inclusion of securities under GSM Framework.
AND
AND
AND
AND
OR
OR
Additional Surveillance Measure (ASM) is part of SEBI and the Exchanges initiative to enhance market integrity and safeguard the interest of investors. The ASM list is a list of securities that are currently getting monitored due to factors like price fluctuation, volatility, volume variance, etc.
The shortlisting of securities under Additional Surveillance Measure (ASM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.
The shortlisting of securities for placing in Additional Surveillance Measure (ASM) framework is based on an objective criteria as jointly decided by SEBI and Exchanges covering the following market based dynamic parameters: